Dr. Elijah Salzer
Purpose: The purpose of this article is to review existing literature regarding the current role of patient preference and life expectancy in the management approach of basal cell carcinoma (BCC) in very elderly patients. Very elderly individuals are identified as those ≥85 years of age. This article aims to further evaluate the potential risks and benefits of treatment of BCC compared to nonintervention in the very elderly with limited life expectancy (LLE).
Current clinical guidelines do not include evaluation of patient preference or life expectancy to determine the appropriate treatment for basal cell carcinoma. In the very elderly population, who are expected to experience an increased incidence of basal cell carcinoma, this consideration could improve patient satisfaction and quality of life while simultaneously decreasing the level of burden to the healthcare system from unnecessary treatment of BCC.
Fahlstrom K. Consideration of Life Expectancy in the Management of Basal Cell Carcinoma. Lynchburg Journal of Medical Science. 2022; 4(4).
Available when accessing via a campus IP address or logged in with a University of Lynchburg email address.
Off-campus users can also use 'Off-campus Download' button above for access.